- Home
- ZTEK vs IAE Comparison
ZTEK vs IAE Comparison
Compare ZTEK & IAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ZTEK | IAE |
|---|---|---|
| Founded | 2008 | 2007 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Trusts Except Educational Religious and Charitable |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 68.8M | 80.3M |
| IPO Year | 2022 | N/A |
Fundamental Metrics
Financial Performance| Metric | ZTEK | IAE |
|---|---|---|
| Price | $0.61 | $7.42 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 123.6K | 57.8K |
| Earning Date | 02-18-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 10.21% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.54 | $5.30 |
| 52 Week High | $1.84 | $8.30 |
Technical Indicators
Market Signals| Indicator | ZTEK | IAE |
|---|---|---|
| Relative Strength Index (RSI) | 42.10 | 39.60 |
| Support Level | $0.55 | $7.40 |
| Resistance Level | $0.67 | $7.56 |
| Average True Range (ATR) | 0.05 | 0.19 |
| MACD | 0.00 | -0.03 |
| Stochastic Oscillator | 53.85 | 29.52 |
Price Performance
Historical ComparisonAbout ZTEK Zentek Ltd.
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.
About IAE Voya Asia Pacific High Dividend Equity Income Fund ING Asia Pacific High Dividend Equity Income Fund of Beneficial Interest
Voya Asia Pacific High Dividend Equity Income Fund is a United States-based diversified, closed-end fund.The investment objective of the fund is to provide a total return through a combination of current income, capital gains, and capital appreciation. To achieve this objective, under normal market conditions, the fund invests in a portfolio of dividend-yielding equity securities of companies located in the Asia Pacific region.